3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
47
Myelodysplastic Syndromes
23
Leukemia, Myelomonocytic, Chronic
10
Leukemia
7
Recurrence
6
Ovarian Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Primary Myelofibrosis
2
Neoplasms
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Melanoma
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Systemic Mastocytosis With an Associated Hematologic Neoplasm
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Sarcoma, Synovial
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pathologic Complete Response
1
Older Patients
1
Myeloid Malignancies
1
Interventions
Magnetic Resonance Spectroscopy
10
trametinib
7
Nivolumab
7
selpercatinib
6
pembrolizumab
6
dabrafenib
6
Iodine-131
6
Specimen Handling
5
Biopsy
5
lenvatinib
4
Vemurafenib
4
Iodine-124
4
durvalumab
3
cabozantinib
3
binimetinib
3
Ipilimumab
3
Immunoglobulin G
3
Fluorodeoxyglucose F18
3
Disulfides
3
Cyclophosphamide
3
Cetuximab
3
vandetanib
2
ulixertinib
2
omipalisib
2
larotrectinib
2
defactinib
2
copanlisib
2
cemiplimab
2
anlotinib
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Decitabine
×
1 year
×
Clear all
No trials found.